[go: up one dir, main page]

Schroeder et al., 2003 - Google Patents

Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia

Schroeder et al., 2003

View HTML
Document ID
4094383618597456259
Author
Schroeder U
Bernt K
Lange B
Wenkel J
Jikai J
Shabat D
Amir R
Huebener N
Niethammer A
Hagemeier C
Wiebusch L
Gaedicke G
Wrasidlo W
Reisfeld R
Lode H
Publication year
Publication venue
Blood

External Links

Snippet

Effective therapy of high-risk leukemia with established cytotoxic drugs may be limited by poor antitumor efficacy, systemic toxicity, and the induction of drug resistance. Here, we provide the first evidence that hydrolytically activated prodrugs may overcome these …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Similar Documents

Publication Publication Date Title
JP5302862B2 (en) Podophyllotoxin
Zou et al. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration
Conze et al. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells
Karikari et al. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein
Petak et al. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines
Snyder et al. Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides
Longley et al. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites
Numbenjapon et al. Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft models
Wu et al. Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells
Henrich et al. New inhibitors of ABCG2 identified by high-throughput screening
Weiss et al. N-alkynyl derivatives of 5-fluorouracil: susceptibility to palladium-mediated dealkylation and toxigenicity in cancer cell culture
Nishiyama et al. Free and N-(2-hydroxypropyl) methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells
Makowski et al. Sudemycin K: a synthetic antitumor splicing inhibitor variant with improved activity and versatile chemistry
Kuthati et al. Synthesis of novel spiro [pyrazolo [4, 3-d] pyrimidinones and spiro [benzo [4, 5] thieno [2, 3-d] pyrimidine-2, 3′-indoline]-2′, 4 (3H)-diones and their evaluation for anticancer activity
Schroeder et al. Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia
Zi et al. Design, synthesis, and biological evaluation of novel biotinylated podophyllotoxin derivatives as potential antitumor agents
Chen et al. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis
Roemhild et al. Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
Menzella et al. Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of Streptomyces hygroscopicus
Beard et al. Synthesis and conformational analysis of FR901464-Based RNA splicing modulators and their synergism in drug-resistant cancers
Takakuwa et al. Over-expression of MDR1 in amrubicinol-resistant lung cancer cells
Huang et al. Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin
Zhang et al. The application of PROTACs in immune-inflammation diseases
Yang et al. AZ960, a novel Jak2 inhibitor, induces growth arrest and apoptosis in adult T-cell leukemia cells
WO2021208787A1 (en) Target polypeptide used for screening drugs and screening method therefor